##gff-version 3
##sequence-region Q15025 1 636
Q15025	UniProtKB	Chain	1	636	.	.	.	ID=PRO_0000096691;Note=TNFAIP3-interacting protein 1	
Q15025	UniProtKB	Region	94	412	.	.	.	Note=Interaction with Nef	
Q15025	UniProtKB	Region	351	367	.	.	.	Note=Interaction with Shigella flexneri ipah9.8	
Q15025	UniProtKB	Region	431	588	.	.	.	Note=Required for inhibitory activity of TNF-induced NF-kappa-B activation;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q15025	UniProtKB	Region	452	510	.	.	.	Note=Ubiquitin-binding domain (UBD)	
Q15025	UniProtKB	Coiled coil	20	73	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q15025	UniProtKB	Coiled coil	196	258	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q15025	UniProtKB	Coiled coil	294	535	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q15025	UniProtKB	Motif	524	530	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q15025	UniProtKB	Compositional bias	539	636	.	.	.	Note=Pro-rich	
Q15025	UniProtKB	Modified residue	77	77	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q15025	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q15025	UniProtKB	Modified residue	403	403	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:16964243,PMID:18669648,PMID:20068231,PMID:23186163	
Q15025	UniProtKB	Modified residue	438	438	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q15025	UniProtKB	Modified residue	442	442	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q15025	UniProtKB	Modified residue	552	552	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17632516;Dbxref=PMID:17632516	
Q15025	UniProtKB	Modified residue	571	571	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9WUU8	
Q15025	UniProtKB	Modified residue	599	599	.	.	.	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15025	UniProtKB	Modified residue	599	599	.	.	.	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15025	UniProtKB	Modified residue	627	627	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q15025	UniProtKB	Alternative sequence	1	53	.	.	.	ID=VSP_045296;Note=In isoform 3. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:17016622,ECO:0000303|PubMed:17974005;Dbxref=PMID:14702039,PMID:17016622,PMID:17974005	
Q15025	UniProtKB	Alternative sequence	530	593	.	.	.	ID=VSP_055208;Note=In isoform 4 and isoform 6. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17016622;Dbxref=PMID:17016622	
Q15025	UniProtKB	Alternative sequence	530	556	.	.	.	ID=VSP_055209;Note=In isoform 5. ASGERYHVEPHPEHLCGAYPYAYPPMP->SLQKMTVRGLSETRLCHLAPPSSCRAS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17016622;Dbxref=PMID:17016622	
Q15025	UniProtKB	Alternative sequence	530	552	.	.	.	ID=VSP_055210;Note=In isoform 8. ASGERYHVEPHPEHLCGAYPYAY->SQLISDCQETRSHLHGVARASAG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17016622;Dbxref=PMID:17016622	
Q15025	UniProtKB	Alternative sequence	530	545	.	.	.	ID=VSP_055211;Note=In isoform 7. ASGERYHVEPHPEHLC->GTHRGCPRRLPERKVK;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17016622;Dbxref=PMID:17016622	
Q15025	UniProtKB	Alternative sequence	546	636	.	.	.	ID=VSP_055212;Note=In isoform 7. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17016622;Dbxref=PMID:17016622	
Q15025	UniProtKB	Alternative sequence	553	636	.	.	.	ID=VSP_055213;Note=In isoform 8. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17016622;Dbxref=PMID:17016622	
Q15025	UniProtKB	Alternative sequence	557	636	.	.	.	ID=VSP_055214;Note=In isoform 5. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17016622;Dbxref=PMID:17016622	
Q15025	UniProtKB	Alternative sequence	627	636	.	.	.	ID=VSP_003913;Note=In isoform 2 and isoform 6. SPKNDREGPQ->PADLRLPRN;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:17016622,ECO:0000303|PubMed:8681136,ECO:0000303|PubMed:9923610;Dbxref=PMID:17016622,PMID:8681136,PMID:9923610	
Q15025	UniProtKB	Natural variant	103	103	.	.	.	ID=VAR_051453;Note=P->S;Dbxref=dbSNP:rs2303018	
Q15025	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_051454;Note=A->V;Dbxref=dbSNP:rs2233289	
Q15025	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_051455;Note=P->A;Dbxref=dbSNP:rs2233290	
Q15025	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_051456;Note=R->Q;Dbxref=dbSNP:rs2233292	
Q15025	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_051457;Note=A->V;Dbxref=dbSNP:rs2233295	
Q15025	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_067965;Note=In patients with gastrointestinal diffuse large cell lymphoma. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21266526;Dbxref=dbSNP:rs117663772,PMID:21266526	
Q15025	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_067966;Note=In patients with gastrointestinal diffuse large cell lymphoma%3B somatic mutation. T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21266526;Dbxref=dbSNP:rs185683917,PMID:21266526	
Q15025	UniProtKB	Natural variant	374	374	.	.	.	ID=VAR_067967;Note=In patients with gastrointestinal diffuse large cell lymphoma. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21266526;Dbxref=dbSNP:rs748495842,PMID:21266526	
Q15025	UniProtKB	Natural variant	476	476	.	.	.	ID=VAR_067968;Note=In patients with gastrointestinal diffuse large cell lymphoma%3B somatic mutation%3B loss of inhibitory activity on CARD11- and TNF-induced NF-kappa-B activation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21266526;Dbxref=PMID:21266526	
Q15025	UniProtKB	Mutagenesis	472	472	.	.	.	Note=Abolishes binding to polyubiquitin ('K-63'-linked and linear). D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21606507;Dbxref=PMID:21606507	
Q15025	UniProtKB	Mutagenesis	552	552	.	.	.	Note=Abolishes interaction with PI3K p85 regulatory subunit and abolishes interaction between SELPLG and PI3K p85 regulatory subunit. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17632516;Dbxref=PMID:17632516	
Q15025	UniProtKB	Sequence conflict	148	148	.	.	.	Note=G->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q15025	UniProtKB	Sequence conflict	178	178	.	.	.	Note=G->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q15025	UniProtKB	Sequence conflict	299	299	.	.	.	Note=A->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q15025	UniProtKB	Sequence conflict	299	299	.	.	.	Note=A->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
